A detailed history of China Universal Asset Management Co., Ltd. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 9,362 shares of AMPH stock, worth $421,851. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,362
Previous 5,745 62.96%
Holding current value
$421,851
Previous $229,000 98.25%
% of portfolio
0.05%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$36.99 - $50.09 $133,792 - $181,175
3,617 Added 62.96%
9,362 $454,000
Q2 2024

Jul 19, 2024

SELL
$38.65 - $43.48 $135,313 - $152,223
-3,501 Reduced 37.87%
5,745 $229,000
Q1 2024

Apr 29, 2024

BUY
$42.85 - $63.45 $158,716 - $235,018
3,704 Added 66.84%
9,246 $406,000
Q4 2023

May 21, 2024

SELL
$44.49 - $62.93 $164,790 - $233,092
-3,704 Reduced 40.06%
5,542 $342,000
Q4 2023

Jan 23, 2024

BUY
$44.49 - $62.93 $190,461 - $269,403
4,281 Added 339.49%
5,542 $343,000
Q3 2023

May 21, 2024

BUY
$45.51 - $65.0 $28,580 - $40,820
628 Added 99.21%
1,261 $57,000
Q3 2023

Oct 30, 2023

BUY
$45.51 - $65.0 $28,580 - $40,820
628 Added 99.21%
1,261 $58,000
Q2 2023

May 21, 2024

SELL
$35.77 - $58.38 $786 - $1,284
-22 Reduced 3.36%
633 $36,000
Q2 2023

Jul 27, 2023

SELL
$35.77 - $58.38 $786 - $1,284
-22 Reduced 3.36%
633 $36,000
Q1 2023

May 21, 2024

BUY
$27.99 - $37.92 $4,590 - $6,218
164 Added 33.4%
655 $24,000
Q1 2023

Apr 27, 2023

BUY
$27.99 - $37.92 $4,590 - $6,218
164 Added 33.4%
655 $25,000
Q4 2022

May 21, 2024

SELL
$27.93 - $31.27 $244,527 - $273,768
-8,755 Reduced 94.69%
491 $13,000
Q4 2022

Jan 31, 2023

BUY
$27.93 - $31.27 $893 - $1,000
32 Added 6.97%
491 $14,000
Q3 2022

Oct 21, 2022

BUY
$27.56 - $37.75 $12,650 - $17,327
459 New
459 $13,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.21B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.